로그인 회원가입
icon_bulk_order대량 주문 Acrobiosystems for English
0
장바구니가 비어 있습니다
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: > GLP1R

GLP1R

요약

Name:Glucagon-like peptide-1
Target Synonym:GLP-1
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:1
Lastest Research Phase:Phase 1 Clinical

라이센싱

Project Name Modality Therapeutic Area Indications Stage Right Available
GLP-1/GIP/GCG fusion protein Fusion/Recombination protein Metabolic disease T2DM,Obesity IND Global
GLP-1/GIP/FGF21 fusion protein Fusion/Recombination protein Metabolic disease NASH,Type 2 diabetes,hyperlipidemia Preclinical Global  (except China)

제품 리스트 구매

일부의 생물활성 데이터

CHEK-ATP160-Cell-based assay
 GLP1R FACS

Expression analysis of human GLP-1R on HEK293/Human GLP-1R Stable Cell Line by FACS.
Cell surface staining using PE-labeled anti-human GLP-1R antibody was performed on HEK293/Human GLP-1R Stable Cell Line with different expression levels: HEK293/Human GLP-1R Stable Cell Line (Low Expression); HEK293/Human GLP-1R Stable Cell Line (Medium Expression); HEK293/Human GLP-1R Stable Cell Line (High Expression).

CHEK-ATP161-Cell-based assay
 GLP1R FACS

Expression analysis of human GLP-1R on HEK293/Human GLP-1R Stable Cell Line by FACS.
Cell surface staining using PE-labeled anti-human GLP-1R antibody was performed on HEK293/Human GLP-1R Stable Cell Line with different expression levels: HEK293/Human GLP-1R Stable Cell Line (Low Expression); HEK293/Human GLP-1R Stable Cell Line (Medium Expression); HEK293/Human GLP-1R Stable Cell Line (High Expression).

GLR-H82E3-BLI
 GLP1R BLI

Loaded Biotinylated Human GLP1R, His,Avitag (Cat. No. GLR-H82E3) on NTA Biosensor, can bind GLP-1 (7-37) with an affinity constant of 1.40 μM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).

GLR-H82E3-ELISA
 GLP1R ELISA

Immobilized Biotinylated Human GLP1R Protein, His,Avitag (Cat. No. GLR-H82E3) at 1 μg/mL (100 μL/well) on streptavidin (Cat. No. STN-N5116) precoated (0.5 μg/well) plate can bind Anti-GLP-R1 Antibody with a linear range of 0.5-31 ng/mL (QC tested).

임상 약품 정보

Name Research Code Research Phase Company Indications Clinical Trials
HM-15275 HM-15275; HM15275 Phase 1 Clinical Hanmi Pharmaceutical Co Ltd Obesity Details

This web search service is supported by Google Inc.

totop